Day: November 24, 2025

ATLANTA, GA, Nov. 24, 2025 (GLOBE NEWSWIRE) — Trust Stamp. (Nasdaq: IDAI), a global provider of AI-powered trust and identity solutions detailed its patent-protected framework for embedding links to a biometrically validated cryptographic chain of provenance directly into stablecoins while highlighting the growing recognition that stablecoins are being used for money laundering and terrorist financing. According to recent updates from the Financial Action Task Force (FATF), stablecoins have become one of the most commonly used virtual assets by illicit actors, including North Korean cybercriminals, terrorist financiers, and drug traffickers and most on-chain illicit activity now involves stablecoins. FATF has warned that mass adoption of stablecoins, combined with uneven global implementation of its standards, creates significant...

ATHENS, Greece, Nov. 24, 2025 (GLOBE NEWSWIRE) — Icon Energy Corp. (“Icon” or the “Company”) (Nasdaq: ICON), an international shipping company providing worldwide seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels, announced today that to date it has sold 132,144 shares of the Company’s common shares pursuant to advances under the Standby Equity Purchase Agreement (“SEPA”) at an average price per share of $1.86. As previously announced, Icon entered into the SEPA with an investor on August 27, 2025. Subject to its terms and conditions, Icon has the right (but not the obligation) to issue to the investor, and the investor has the obligation to purchase up to $20 million worth of the Company’s common shares over a period of three years. Icon believes that the SEPA provides a flexible and efficient...

French limited company (Société anonyme) with registered capital of 106,640,982.60 eurosRegistered office: 14, rue Royale, 75008 Paris632 012 100 R.C.S. ParisLegal Entity Identifier: 529900JI1GG6F7RKVI53 Disclosure of total number of voting rights and number of sharesin the capital at October 31, 2025 Pursuant to article L-233-8 II of the French “Code de Commerce” and 223-16 of the AMF’s General Regulations:Total number of shares 533,752,570Number of real voting rights (excluding treasury shares) 533,752,570Theoretical number of voting rights (including treasury shares*)(*) pursuant to article 223-11 of the AMF’s General Regulations 533,752,570About L’Oréal For 115 years, L’Oréal, the world’s leading beauty player, has devoted itself to one thing only: fulfilling the beauty aspirations of consumers around the world....

Urbo bankas UAB (hereinafter – “the Bank”), company code 112027077, address: Konstitucijos pr.18B, Vilnius. In the first three quarters of this year, Lithuania-based Urbo Bankas recorded double-digit growth in both its loan and deposit portfolios. Year-to-date, the bank’s loans have grown by more than 26% (from EUR 414.5 million) and deposits by 22% (from EUR 557.3 million). “This year, we have continued our consistent growth in both deposit and loan categories. In order to strengthen the bank’s capital base and support our ambitious growth targets, we launched our second subordinated bond issue in early October. In the first stage of the placement, we successfully raised almost EUR 7 million,” said Marius Arlauskas, Chief Executive Officer of Urbo Bankas. In the first nine months, Urbo Bankas earned a net profit of EUR 4.4 million,...

Clinical validation successfully completed with Mayo Clinic Platform’s Validate program – marking the final clinical requirement prior to FDA 510(k) submission  EchoSolv HF validation met the primary endpoint, delivering performance exceeding company expectations in detecting heart failure on an independent dataset Study was undertaken across 17,000 individual patient echocardiograms from the Mayo Clinic Platform with results highlighting:Sensitivity of 99.5%, accurately identifying true positives Specificity of 91.0%, detecting true negativesFDA 510(k) submission now being finalised with lodgement expected in the coming weeks Company to leverage existing footprint in the US market to drive uptake of EchoSolv HF post potential FDA clearance FDA clearance of EchoSolv HF would unlock a major market opportunity in the US:Only...

Expanding commercial reach and advancing lung imaging innovation in Asia-PacificDK Medical and Polarean enter international distribution partnershipDK is a leading provider of diagnostic radiology systems and imaging technologies in KoreaDURHAM, NC and LONDON, Nov. 24, 2025 (GLOBE NEWSWIRE) — Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in functional Magnetic Resonance Imaging (“MRI”) of the lungs, announces it has signed an exclusive distribution agreement with DK Healthcare Co., Ltd. (“DK Healthcare”) for the distribution of Polarean’s Xenon MRI platform in South Korea. This agreement represents Polarean’s second international distribution partnership, strengthening the Company’s commercial presence across the Asia-Pacific region. Through...

ATHENS, Greece, Nov. 24, 2025 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX) (“Diana” or the “Company”) announced that today it has submitted a letter to the Board of Directors of Genco Shipping & Trading Limited (NYSE: GNK) (“Genco”) setting forth a proposal to acquire all of the outstanding shares of Genco not already owned by Diana for $20.60 per share in cash. The Company currently owns approximately 14.8% of Genco’s outstanding shares. The proposed price represents: a 15% premium to the closing price of Genco’s shares on November 21, 2025; a 21% premium to the closing price of Genco’s shares on July 17, 2025, the date of the initial disclosure of Diana’s ownership stake in Genco; and a 23% premium to the volume-weighted average price of Genco’s shares for each of the 30-day and 90-day periods ending November 21,...

Live webcast fireside chat on Tuesday, December 2nd at 10:00 AM ET ISELIN, N.J., Nov. 24, 2025 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that Bob Jahr, Chief Executive Officer of Outlook Therapeutics, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 10:00 AM ET. In addition to the fireside chat, management will be available to participate in one-on-one in-person meetings with qualified members of the investor community who are registered to attend the conference. A live webcast of the fireside chat will be accessible on the Events page in the Investors section of the Company’s website (outlooktherapeutics.com)....

Partnership deal represents the intersection of AI, digital asset creation, and geology PHILADELPHIA, Nov. 24, 2025 (GLOBE NEWSWIRE) — via IBN – Datavault AI (“Datavault AI” or the “Company”) (NASDAQ: DVLT), a provider of data monetization, credentialing, digital engagement, and real‑world asset digitization technologies, today announced a $7 million minting deal and a 30% perpetual royalty partnership with Tanzania-based MTB Mining Limited (MTB), setting the stage for what Datavault AI believes is the first major step forward in modernizing how mineral resources are verified, documented, and brought into global commerce with a unified transaction ledger. The deal redefines a commodity by digitizing Real World Assets (RWA) for monetization. Under Datavault AI’s patented Sumerian® technology, rare earth minerals are being transformed...